Lixin Wang

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Acute Myeloid Leukemia

Inflammatory Response

Top Venues

Blood cancer journal

Leukemia & lymphoma

Chinese PLA General Hospital (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Chinese PLA General Hospital Aug 01 2007 - Jun 30 2010

China

PHD

Publications

Lixin Wang, Chuling Fang, Qingzheng Kang, Wenfa Huang, Ziren Chen, Weiqiang Zhao, Lei Wang, Yiran Wang, Kun Tan, Xiao Guo, Yuanyuan Xu, Shuhong Wang, Lijun Wang, Jingqiao Qiao, Zhixiong Tang, Chuan Yu, Yang Xu, Yisheng Li, Li Yu
Bispecific CAR-T cells targeting CD19/20 in patients with relapsed or refractory B cell non-Hodgkin lymphoma: a phase I/II trial. Blood cancer journal 14 (1) (2024)
Lixin Wang, Chuling Fang, Qingzheng Kang, Wenfa Huang, Ziren Chen, Weiqiang Zhao, Lei Wang, Yiran Wang, Kun Tan, Xiao Guo, Yuanyuan Xu, Shuhong Wang, Lijun Wang, Jingqiao Qiao, Zhixiong Tang, Chuan Yu, Yang Xu, Yisheng Li, Li Yu
Bispecific CAR-T cells targeting CD19/20 in patients with relapsed or refractory B cell non-Hodgkin lymphoma: a phase I/II trial. Blood cancer journal 14 (1) (2024)
Lixin Wang, Chuling Fang, Qingzheng Kang, Wenfa Huang, Ziren Chen, Weiqiang Zhao, Lei Wang, Yiran Wang, Kun Tan, Xiao Guo, Yuanyuan Xu, Shuhong Wang, Lijun Wang, Jingqiao Qiao, Zhixiong Tang, Chuan Yu, Yang Xu, Yisheng Li, Li Yu
Bispecific CAR-T cells targeting CD19/20 in patients with relapsed or refractory B cell non-Hodgkin lymphoma: a phase I/II trial. Blood cancer journal 14 (1) (2024)
Zhiding Wang, Wei Guan, Mengzhen Wang, Jinghong Chen, Linlin Zhang, Yang Xiao, Lixin Wang, Yonghui Li, Li Yu
AML1-ETO inhibits acute myeloid leukemia immune escape by CD48. Leukemia & lymphoma 62 (4) (2020)